These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9689811)

  • 1. Cellular immunity and immunotherapy against deoxyribonucleic acid virus-induced tumors.
    Macedo MF; Velders MP; Nieland JD; Rudolf MP; Weijzen S; Da Silva DM; Franke A; Holt G; Loviscek K; Carbone M; Kast WM
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):211-8. PubMed ID: 9689811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape.
    Toes RE; Feltkamp MC; Ressing ME; Vierboom MP; Blom RJ; Brandt RM; Hartman M; Offringa R; Melief CJ; Kast WM
    Biochem Soc Trans; 1995 Aug; 23(3):692-6. PubMed ID: 8566445
    [No Abstract]   [Full Text] [Related]  

  • 3. [Perspectives for the immunotherapy of condylomata].
    Bourgault Villada I
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S23-3S25. PubMed ID: 11116860
    [No Abstract]   [Full Text] [Related]  

  • 4. Concepts of wart regression.
    Bender ME
    Arch Dermatol; 1986 Jun; 122(6):644-7. PubMed ID: 3013101
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors.
    Torréns I; Mendoza O; Batte A; Reyes O; Fernández LE; Mesa C; Guillén G
    Vaccine; 2005 Dec; 23(50):5768-74. PubMed ID: 16112257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human malignant mesothelioma of the pleura: new perspectives for diagnosis and therapy.
    Procopio A; Strizzi L; Giuffrida A; Scarpa S; Giuliano M; Iezzi T; Mutti L; Modesti A
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):241-3. PubMed ID: 9689815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
    Chen CH; Ji H; Suh KW; Choti MA; Pardoll DM; Wu TC
    Gene Ther; 1999 Dec; 6(12):1972-81. PubMed ID: 10637448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity.
    Rooney CM; Smith CA; Heslop HE
    Mol Med Today; 1997 Jan; 3(1):24-30. PubMed ID: 9021739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignancies induced by human papilloma virus].
    Jabłońska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obałek S; Gliński W; Favre M; Croissant O
    Przegl Dermatol; 1978; 65(5):497-50. PubMed ID: 214825
    [No Abstract]   [Full Text] [Related]  

  • 11. The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans.
    Matker CM; Rizzo P; Pass HI; Di Resta I; Powers A; Mutti L; Kast WM; Carbone M
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):193-7. PubMed ID: 9689808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of recipients' immune status on effectiveness of adoptive immunotherapy with TAA specific T lymphocytes and interleukin-2 in CBA polyoma mice.
    Ochalek T
    Neoplasma; 1991; 38(2):199-206. PubMed ID: 1645851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
    Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cytotoxic T lymphocytes against virus-induced tumors.
    Melief CJ; Kast WM
    Cancer Cells; 1990 Apr; 2(4):116-20. PubMed ID: 2143919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles for adoptive T cell therapy of human viral diseases.
    Riddell SR; Greenberg PD
    Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for an SV40 vaccine.
    Imperiale MJ; Pass HI; Sanda MG
    Semin Cancer Biol; 2001 Feb; 11(1):81-5. PubMed ID: 11243902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of human papillomavirus infection in lower genital tract neoplasia.
    Man S; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):701-14. PubMed ID: 11563868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
    Aldrich JF; Shearer MH; Lowe DB; Winn RE; Jumper CA; Kennedy RC; Bright RK
    Cancer Immunol Immunother; 2013 Feb; 62(2):371-82. PubMed ID: 22926061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomavirus virus-like particles as anticancer vaccines.
    Da Silva DM; Velders MP; Rudolf MP; Schiller JT; Kast WM
    Curr Opin Mol Ther; 1999 Feb; 1(1):82-8. PubMed ID: 11249689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from T cell responses to virus induced tumours for cancer eradication in general.
    Melief CJ; Kast WM
    Cancer Surv; 1992; 13():81-99. PubMed ID: 1423326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.